NCT06649747View on ClinicalTrials.gov

Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

408

Participants

Timeline

Start Date

April 1, 2027

Primary Completion Date

March 31, 2032

Study Completion Date

March 31, 2032

Conditions

Lumbosacral Radiculopathy

Interventions

DRUG

AFA-281

A small molecule, orally available

All Listed Sponsors

lead

Afasci Inc

INDUSTRY